Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

The psychosis risk factor RBM12 encodes a novel repressor of GPCR/cAMP signal transduction

Khairunnisa M. Semesta, Angelica Garces, View ORCID ProfileNikoleta G. Tsvetanova
doi: https://doi.org/10.1101/2023.01.12.523776
Khairunnisa M. Semesta
1Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Angelica Garces
1Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nikoleta G. Tsvetanova
1Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nikoleta G. Tsvetanova
  • For correspondence: nikoleta.tsvetanova@duke.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Preview PDF
Loading

Abstract

RBM12 is a high-penetrance risk factor for familial schizophrenia and psychosis, yet its precise cellular functions and the pathways to which it belongs are not known. We utilize two complementary models, HEK293 cells and human iPSC-derived neurons, and delineate RBM12 as a novel repressor of the G protein-coupled receptor/cyclic AMP/protein kinase A (GPCR/cAMP/PKA) signaling axis. We establish that loss of RBM12 leads to hyperactive cAMP production and increased PKA activity as well as altered neuronal transcriptional responses to GPCR stimulation. Notably, the cAMP and transcriptional signaling steps are subject to discrete RBM12-dependent regulation. We further demonstrate that the two RBM12 truncating variants linked to familial psychosis impact this interplay, as the mutants fail to rescue GPCR/cAMP signaling hyperactivity in cells depleted of RBM12. Lastly, we present a mechanism underlying the impaired signaling phenotypes. In agreement with its activity as an RNA-binding protein, loss of RBM12 leads to altered gene expression, including that of multiple effectors of established significance within the receptor pathway. Specifically, the abundance of adenylyl cyclases, phosphodiesterase isoforms, and PKA regulatory and catalytic subunits is impacted by RBM12 depletion. We note that these expression changes are fully consistent with the entire gamut of hyperactive signaling outputs. In summary, the current study identifies a previously unappreciated role for RBM12 in the context of the GPCR/cAMP pathway that could be explored further as a tentative molecular mechanism underlying the functions of this factor in neuronal physiology and pathophysiology.

Competing Interest Statement

The authors have declared no competing interest.

Footnotes

  • Figure file quality

Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted January 13, 2023.
Download PDF

Supplementary Material

Email

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
The psychosis risk factor RBM12 encodes a novel repressor of GPCR/cAMP signal transduction
(Your Name) has forwarded a page to you from bioRxiv
(Your Name) thought you would like to see this page from the bioRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
The psychosis risk factor RBM12 encodes a novel repressor of GPCR/cAMP signal transduction
Khairunnisa M. Semesta, Angelica Garces, Nikoleta G. Tsvetanova
bioRxiv 2023.01.12.523776; doi: https://doi.org/10.1101/2023.01.12.523776
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
The psychosis risk factor RBM12 encodes a novel repressor of GPCR/cAMP signal transduction
Khairunnisa M. Semesta, Angelica Garces, Nikoleta G. Tsvetanova
bioRxiv 2023.01.12.523776; doi: https://doi.org/10.1101/2023.01.12.523776

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Cell Biology
Subject Areas
All Articles
  • Animal Behavior and Cognition (4843)
  • Biochemistry (10771)
  • Bioengineering (8031)
  • Bioinformatics (27249)
  • Biophysics (13959)
  • Cancer Biology (11108)
  • Cell Biology (16026)
  • Clinical Trials (138)
  • Developmental Biology (8770)
  • Ecology (13266)
  • Epidemiology (2067)
  • Evolutionary Biology (17338)
  • Genetics (11678)
  • Genomics (15902)
  • Immunology (11011)
  • Microbiology (26033)
  • Molecular Biology (10625)
  • Neuroscience (56450)
  • Paleontology (417)
  • Pathology (1729)
  • Pharmacology and Toxicology (2999)
  • Physiology (4539)
  • Plant Biology (9614)
  • Scientific Communication and Education (1612)
  • Synthetic Biology (2682)
  • Systems Biology (6967)
  • Zoology (1508)